# ClinicalTrials.gov record NCT07220759

> PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07220759-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-03
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07220759-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07220759-cagrilintide-v1.json
- Content SHA-256: `a7ebc2289de147e8112420d56fe97a106386009733a79f6878fa97364cdc2a0a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07220759 ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

## Sources

<a id="source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd"></a>
- **ClinicalTrials.gov record NCT07220759 · retained source version 2026-08-03:50fb10a6adbd81022c8cc1ee950e283b46f97533acbf5a944399ee4e77eaceb1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07220759) (`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07220759." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07220759-cagrilintide-v1.json SHA-256: a7ebc2289de147e8112420d56fe97a106386009733a79f6878fa97364cdc2a0a.